HOME >> MEDICINE >> NEWS
Many Americans at high risk of vision loss do not have access to eye care

Data from a national survey suggest that an estimated 60 million American adults are at high risk of vision loss, according to a report published in the March issue of Archives of Ophthalmology, one of the JAMA/Archives journals. Of those adults, one in 12 cannot afford eyeglasses when needed, and about one-half do not get dilated eye examinations on a yearly basis.

In 2000, about 3.3 million Americans age 40 or older were visually impaired and more than 11 million of those age 12 and older needed glasses or contact lenses, according to background information in the article. By 2020, these numbers could increase by 50 percent or more. Eye diseases and vision problems are associated with increased illness, increased risk of death and decreased quality of life. They also are causes of falls and injuries and can lead to depression and social isolation.

Xinzhi Zhang, M.D., Ph.D., Centers for Disease Control and Prevention, Atlanta, and colleagues used data on vision from the 2002 National Health Interview Survey to estimate the number of U.S. adults at high risk of vision loss and assess factors associated with the use of eye care services. A total of 30,920 adults age 18 or older participated in the survey, designed to be representative of the entire U.S. population.

Sixteen percent of the participants were age 65 years or older, 6.5 percent had diabetes and 19.5 percent had vision or eye problems. Based on these percentages, the authors project that an estimated 61 million American adults are at high risk of serious vision loss. The researchers estimated that of those, only half visited an eye doctor in the past 12 months and half had dilated eye examination, in which eyedrops are administered to widen the pupil, allowing a more thorough inspection of the eyes. Yearly exams are recommended for those with diabetes or who are age 65 or older. About one-third of the estimated 144 million U.S. individuals not at high risk of seriou
'"/>

Contact: Rachel Ciccarone
770-488-5131
JAMA and Archives Journals
12-Mar-2007


Page: 1 2 3

Related medicine news :

1. Limiting eligibility for medical studies can omit women and African-Americans
2. African-Americans perceive people with extreme health problems as less productive and valuable
3. Hair straightening chemicals not linked to breast cancer risk in African-Americans
4. Urologic diseases cost Americans $11B a year
5. Outdated policies are impediment for Americans with disabilities
6. Health insurance fails to protect Americans from financial risk
7. Americans still not eating enough fruits and vegetables, according to 2 recent studies
8. Civic engagement keeps aging Americans mentally healthy after physical decline
9. Americans believe global warming is real, want action, but not as a priority
10. Americans fear decline in US performance in math and science
11. New report reveals African-Americans may lack key nutrients for optimal health

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Many Americans high risk vision loss not have access eye care

(Date:8/31/2015)... ... August 31, 2015 , ... ... at Monmouth, was one of the first doctors in the area to perform ... new approach have been impressive: faster recovery, decreased immediate and long-term pain, and ...
(Date:8/31/2015)... ... ... Docs Presents, Dr. Michael Betsy! Dr. Betsy has been reviewed and approved as an ... from Don Bosco Prep in 1990 and was Class Salutatorian. He earned Varsity letters ... senior year. He was inducted into the National Honor Society as a sophomore, was ...
(Date:8/31/2015)... ... 31, 2015 , ... With the FCPX LUT Soft pack from Pixel Film Studios, editors can ... that contains a mathematical formula for modifying an image. The LUT changes every pixel's color ... LUT files. , FCPX LUT Soft requires Final Cut Pro X 10.2 or newer. ...
(Date:8/31/2015)... ... August 31, 2015 , ... How can healthcare meet the ... costs? , In a commentary for The American Journal of Managed Care ... “clinical efficacy,” which would bind parties together in agreements to intervene at the ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... and digital marketing communications company announced today that it has officially launched a ... President, the new website and brand refresh are more closely aligned with the ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 4Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:Pixel Film Studios, FCPX Plugin Developer, Releases FCPX LUT Soft 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 3Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3
(Date:8/31/2015)... Aug. 31, 2015  Asterias Biotherapeutics, Inc. (NYSE ... emerging field of regenerative medicine, today announced that ... Chicago -based Rush University Medical Center ... of escalating doses of AST-OPC1 (oligodendrocyte progenitor cells) ... complete cervical spinal cord injury (SCI). This represents ...
(Date:8/31/2015)... -- Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company focused ... the treatment of diseases of the central nervous system ... submission has passed review by the US Food and ... 1 clinical trial in patients with metastatic colon cancer ... 31 December 2015. Bionomics, CEO & Managing ...
(Date:8/30/2015)... ANDOVER, Massachusetts y LONDRES, August 30, 2015 ... conectada ofrece una visión holística de l ... de todo el trayecto   ... anunciado hoy el debut europeo de IntelliSpace Cardiovascular ... información que ofrece sofisticadas herramientas para acceder, analizar y ...
Breaking Medicine Technology:Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3
Cached News: